- Latest Titles
- Featured Titles
Tuberculosis, or TB, is an infectious bacterial disease caused
by Mycobacterium tuberculosis, which most commonly affects the lungs. It is
transmitted from person to person via droplets from the throat and lungs of
people with the active respiratory disease.
Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active TB.
The first edition of Guidance for national tuberculosis programmes on the management of tuberculosis in children was published in 2006. It resulted in the revision or development of guidelines for child TB management by national TB programmes in many TB-endemic countries. Now, however, newly published evidence and new recommendations have made it necessary to update the original 2006 guidance.
This is the nineteenth global report on tuberculosis (TB) published by WHO in a series that started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and financing TB prevention, care and control at global, regional and country levels using data reported by over 200 countries that account for over 99% of the world's TB cases.
Country health information systems provide a rich source of data on the burden of disease caused by tuberculosis (TB) and the effectiveness of programmatic efforts to reduce this burden, both of which are crucial for public health action.
The emergence of drug resistance is a major threat to global tuberculosis (TB) care and control. The World Health Organization (WHO) estimates that up to half a million new cases of multidrug-resistant tuberculosis (MDR-TB) cases (i.e. resistant to, at least, rifampicin and isoniazid) occur each year globally.
This document presents the first comprehensive assessment by WHO of the appropriateness of screening for active TB since the recommendations made in 1974 by the Expert Committee.
Laboratory biosafety is the process of applying a combination of administrative controls, containment principles, practices and procedures, safety equipment, emergency preparedness, and facilities to enable laboratory staff to work safely with potentially infectious microorganisms; biosafety also aims at preventing unintentional exposure to pathogens or their accidental release.
Recommendations for Investigating Contacts of Persons with Infectious Tuberculosis in Low- and middle-income Countries
Tuberculosis (TB) contacts are people who have close contact with patients with infectious TB. As they are at high risk for infection (and in line with the Stop TB strategy), TB contacts should be investigated systematically and actively for TB infection and disease. Such interventions are called 'tuberculosis contact investigations'.
World Health Organization
AXELOS Global Best Practice
- AXELOS Promotions
- PRINCE2 Project Management
- PRINCE2 Agile
- MSP Programme Management
- MOP Portfolio Management
- MOR Risk Management
- MOV - Value Management
- P3O Portfolio, Programme and Project Offices
- ITIL Self-Assessment
- RESILIA FRONTLINE
- Online Access
- AXELOS Membership
- AXELOS Training Courses
- Driver & Vehicle Standards Agency
- Financial Conduct Authority FCA
- The Gazette
- Council of Europe
- Code of Federal Regulations (CFR)
- Health and Safety Executive
- International Monetary Fund
- United Nations
- World Bank
- World Health Organization
- World Tourism Organization
- Clearance Sale
Life in the UK
- About the test
- Official practice test
- Life in the United Kingdom - A Guide for New Residents
- Life in the United Kingdom - Official Practice Questions and Answers
- Life in the United Kingdom - Official Study Guide
- A Practical Guide to Living in the United Kingdom
- Life in the United Kingdom - Four Book Pack
- Daily List